Lawrence, KS, United States
Lawrence, KS, United States

The University of Kansas is a public research university and the largest and oldest public university in the U.S. state of Kansas. KU campuses are located in Lawrence, Wichita, Overland Park, Salina, and Kansas City, Kansas, with the main campus located in Lawrence on Mount Oread, the highest location in Lawrence. The university was opened in 1866, under a charter granted by the Kansas Legislature in 1864 following enabling legislation passed in 1863 under the Kansas Constitution.The university's Medical Center and University Hospital are located in Kansas City, Kansas. The Edwards Campus is in Overland Park, Kansas, in the Kansas City metropolitan area. There are also educational and research sites in Parsons and Topeka, and branches of the University of Kansas School of Medicine in Wichita and Salina.Enrollment at the Lawrence and Edwards campuses was 23,597 students in fall 2014; an additional 3,371 students were enrolled at the KU Medical Center for a total enrollment of 26,968 students across the three campuses. The university overall employed 2,663 faculty members in fall 2012.The 2014 U.S. News & World Report rankings listed KU as 101st in the category "national universities" and 47th among public universities. The U.S. News & World Report "Americas Best Graduate Schools" rankings have ranked 49 KU programs since 2008, 35 of which are ranked in the top 40 among public university programs. The university is one of the 62 members of the Association of American Universities. Wikipedia.


Time filter

Source Type

Patent
University of Kansas and University of Southern California | Date: 2016-10-31

Modified fungal strains having deleted gene clusters are provided. The modified fungal strains include A. nidulans. The deleted gene clusters are selected from the group of gene clusters responsible for the biosynthesis of sterigmatocystin, emericellamides, asperfuranone, monodictyphenone, terrequinone, F9775A, F9775B, asperthecin, and both portions of the split cluster that makes austinol and dehydroaustinol. Methods for making compounds by culturing the fungus in a growth media and separating the compound from the fungus and/or separating the compound from the growth media are included, as are the compounds and compositions comprising them.


Patent
University of Kansas | Date: 2017-01-06

A fluid sensing device includes an outer body, an inner body coupled to the outer body by one or more inner body support struts and extending at least partially out from the outer body, and an aft body disposed at least partially within the outer body at a location aft of the inner body, the aft body being coupled to the outer body by one or more aft body support struts. The inner body includes a hollow interior for housing one or more inner body sensors, and the aft body houses one or more aft body sensors. The fluid sensing device can measure one or more parameters of fluid flow at high angularity, such as total temperature and total pressure, locally and simultaneously, allowing additional fluid parameters, such as local entropy, to be calculated.


Patent
University of Kansas | Date: 2017-01-30

The present disclosure relates to devices and methods for delivery of a ferrofluid to a targeted treatment site, such as delivery of a ferroadhesive to a pathological fistula to occlude the fistula. A device includes a catheter having a lumen and a distal opening. A hollow solenoid is coupled to a distal section of the catheter, and a hollow core of the solenoid allows passage of a ferrofluid through the catheter and through the hollow core so that it may exit past the distal end of the hollow solenoid. The solenoid may be selectively actuated to maintain or control the position of the delivered ferrofluid.


Provided herein are compounds of the formulas: (I) wherein: n, X2, R3, R3, R4, R4, R5, R5, R6, and R6 are as defined herein. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including diabetic peripheral neuropathy or cancer.


Patent
University of Kansas | Date: 2017-04-12

A pharmaceutical composition can include: a marmelin analog compound, and a pharmaceutically acceptable carrier having the compound. The compound can be present in a therapeutically effective amount to treat or inhibit a disease state. The disease state can be cancer. The cancer can be selected from brain cancers, head and neck cancers, thyroid cancers, gastrointestinal cancers, esophageal cancers, stomach cancers, pancreatic cancers, liver cancers, colo-rectal cancers, lung cancers, kidney cancers, prostate cancers, bladder cancers, testicular cancers, breast cancers, ovarian cancers, cervical cancers, and melanomas. The carrier includes a cyclodextrin, which may form a complex with the compound. The compounds and compositions can be used to treat or inhibit progression of cancers. Colo-rectal, bladder, and prostate cancers are examples of some of the cancers that can be treated with the marmelin analog compounds.


Patent
University of Kansas | Date: 2017-03-06

A device for studying protein conformation transformation can include a macroscopic substrate, and chaperonin proteins bound to the substrate, each chaperonin protein being capable of binding to a protein of interest during or after undergoing protein conformation transformation. The device may also include the proteins of interest bound to the substrate, where the substrate is included in a label-free assay system. A method of studying protein conformation transformation can include: providing a macroscopic substrate bound with the chaperonin protein and immersing the chaperonin protein in a study composition having the protein of interest, or include providing a macroscopic substrate bound with the protein of interest; and immersing the protein in a study composition having the chaperonin. Such a method can be done with and without a potential stabilizer in order to determine whether the potential stabilizer stabilizes the protein of interest.


Patent
University of Kansas, University of Louisville and Southern Research Institute | Date: 2017-02-27

The present technology relates to compounds and compositions of Formulas and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).


Patent
University of Kansas | Date: 2017-05-17

Cyclic tetrapeptide stereochemical isomers of CJ-15,208, pharmaceutical compositions from such cyclic tetrapeptides, and methods of using such pharmaceutical compositions. The cyclic tetrapeptide compounds and pharmaceutical compositions disclosed herein are potent analgesics active in several pain models with generally minimal tolerance and reduced likelihood to induce addiction relative to other known opiates.


Patent
The United States As Represented By The Secretary and University of Kansas | Date: 2017-04-19

Disclosed are compounds of formula (I), formula (II), and formula (III): wherein Ar, R1, A, and X are as defined in the specification. These compounds are antiviral agents and are contemplated for use in the treatment of viral infections, for example, hepatitis C. These compounds are also contemplated for use in treating or preventing cancers.


Patent
University of Kansas | Date: 2017-04-19

Provided herein are compounds of the formulas:. which are 90-kDa heat shock protein inhibitors. Pharmaceutical compositions of the compounds are also provided. In some aspects, these compounds may be used for the treatment of diseases, including cancer, e.g., cancers of the breast, the prostate, and the head & neck.

Loading University of Kansas collaborators
Loading University of Kansas collaborators